Anti-SARS-Cov-2 S-RBD IgG Formed after BNT162b2 Vaccination Can Bind C1q and Activate Complement
Background. The ability of vaccine-induced antibodies to bind C1q could affect pathogen neutralization. In this study, we investigated C1q binding and subsequent complement activation by anti-spike (S) protein receptor-binding domain (RBD) specific antibodies produced following vaccination with eith...
Saved in:
Main Authors: | Anas H. A. Abu-Humaidan, Fatima M. Ahmad, Dima Awajan, Raba’a F. Jarrar, Nader Alaridah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/7263740 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura
by: A. K. Ghosh, et al.
Published: (2022-01-01) -
Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
by: Dogan Mustafa, et al.
Published: (2023-06-01) -
Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera
by: Thomas E. Hickey, et al.
Published: (2025-01-01) -
Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescentsResearch in context
by: Qiong Wu, et al.
Published: (2025-01-01) -
Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus
by: Qingjun Pan, et al.
Published: (2016-01-01)